Correlation Between Bristol Myers and Xylo Technologies

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Xylo Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Xylo Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Xylo Technologies, you can compare the effects of market volatilities on Bristol Myers and Xylo Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Xylo Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Xylo Technologies.

Diversification Opportunities for Bristol Myers and Xylo Technologies

0.17

Correlation Coefficient

Bristol Myers  Xylo Technologies

Average diversification

The 3 months correlation between Bristol and Xylo is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Xylo Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xylo Technologies and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Xylo Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xylo Technologies has no effect on the direction of Bristol Myers i.e., Bristol Myers and Xylo Technologies go up and down completely randomly.

Pair Corralation between Bristol Myers and Xylo Technologies

Considering the 90-day investment horizon Bristol Myers is expected to generate 17.77 times less return on investment than Xylo Technologies. But when comparing it to its historical volatility, Bristol Myers Squibb is 4.9 times less risky than Xylo Technologies. It trades about 0.04 of its potential returns per unit of risk. Xylo Technologies is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  354.00  in Xylo Technologies on October 26, 2024 and sell it today you would earn a total of  116.00  from holding Xylo Technologies or generate 32.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Xylo Technologies

Bristol Myers Squibb

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Xylo Technologies

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Xylo Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Xylo Technologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Xylo Technologies

The main advantage of trading using opposite Bristol Myers and Xylo Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Xylo Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xylo Technologies will offset losses from the drop in Xylo Technologies' long position.

The idea behind Bristol Myers Squibb and Xylo Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.